Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

NAUT

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NAUT
FechaHoraFuenteTítuloSímboloCompañía
30/04/202407:00GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/04/202407:00GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
06/03/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAUTNautilus Biotechnology Inc
06/03/202415:39Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NAUTNautilus Biotechnology Inc
05/03/202415:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202407:00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202406:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202406:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAUTNautilus Biotechnology Inc
28/02/202406:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202406:04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NAUTNautilus Biotechnology Inc
22/02/202407:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
07/02/202407:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:NAUTNautilus Biotechnology Inc
30/11/202307:00GlobeNewswire Inc.Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics AwardNASDAQ:NAUTNautilus Biotechnology Inc
01/11/202307:05GlobeNewswire Inc.Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell DevelopmentNASDAQ:NAUTNautilus Biotechnology Inc
31/10/202315:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
31/10/202307:05GlobeNewswire Inc.Nautilus Biotechnology Reports Third Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/10/202307:05GlobeNewswire Inc.Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023NASDAQ:NAUTNautilus Biotechnology Inc
06/09/202306:30GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming September Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
04/08/202307:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming August Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
02/08/202306:30GlobeNewswire Inc.Nautilus Biotechnology Reports Second Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/07/202308:23GlobeNewswire Inc.Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023NASDAQ:NAUTNautilus Biotechnology Inc
21/06/202305:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NAUTNautilus Biotechnology Inc
24/05/202307:05GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming June Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
02/05/202305:30GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
02/05/202305:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NAUTNautilus Biotechnology Inc
27/04/202315:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NAUTNautilus Biotechnology Inc
27/04/202315:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NAUTNautilus Biotechnology Inc
18/04/202315:05GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023NASDAQ:NAUTNautilus Biotechnology Inc
23/03/202307:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
07/03/202307:00GlobeNewswire Inc.Nautilus Biotechnology Announces “First Access Challenge” WinnersNASDAQ:NAUTNautilus Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:NAUT

Su Consulta Reciente

Delayed Upgrade Clock